标普和纳斯达克内在价值 联系我们

Traws Pharma, Inc. TRAW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+550.4%

Traws Pharma, Inc. (TRAW) — 分析师展望 / 分析师共识目标价为.

分析师共识目标价为 $8.00, 上涨空间为 550.4% 相对于当前价格 $1.23.

分析师预估 每股收益(EPS)为 $-154.35 和 营收为 $0.00B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-6.58 vs 预期 $-154.35 (超预期 +95.7%). 分析师准确度: 0%.

TRAW 股票 — 12个月价格预测

$8.00
▲ +550.41% 上涨空间
平均目标价
Based on 0 Wall Street analysts offering 12-month price targets for Traws Pharma, Inc., the price target is $8.00.
平均目标价相对最新价格 $1.23 变动 +550.41%

EPS 预测 — TRAW

0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$6.58 vs Est –$154.35 ▲ 2,245.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

营收预测 — TRAW

98%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 1.8% off
Revenue Trend
Analysts expect stable revenue going forward.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言